1709.4000 -18.10 (-1.05%)
NSE Jul 16, 2025 11:04 AM
Volume: 634.9K
 

BOB Capital Markets Ltd.
Sales/EBITDA/APAT were lower than our estimates by 3.5%/9.6%/29.4%. ETR for 4QFY25 stood at 32.9% including 1x tax expense of Rs 3.7bn
Sun Pharmaceutical Industries Ltd. is trading below its 150 day SMA of 1730.3
More from Sun Pharmaceutical Industries Ltd.
Recommended